Laurus Labs gets USFDA nod to Hydroxychloroquine tablets for treating malaria Farhat Nasim12 March 2019 12:01 PM ISTHydroxychloroquine tablet is also used, usually with other medications, to treat certain auto-immune diseases (lupus, rheumatoid arthritis) when other...
USFDA accepts Allergan license applications to expand Botox label Farhat Nasim11 March 2019 9:30 AM IST"The FDA's acceptance of Allergan's supplemental biologics license applications is a monumental milestone on our journey to bring new treatment...
Lupin gets USFDA nod for Atorvastatin Calcium tablets to lower cholesterol Farhat Nasim8 March 2019 9:45 AM ISTAtorvastatin Calcium tablets are indicated to lower cholesterol in blood for adults and children over 10 years of age, Lupin said. It works by...
Alembic Pharma JV Aleor gets USFDA nod for Clobetasol Propionate ointment Farhat Nasim6 March 2019 9:45 AM ISTThe company's JV, Aleor Dermaceuticals Ltd, has received approval from the US Food and Drug Administration (USFDA) for its abbreviated new drug...
Lupin, Natco receives USFDA nod for Imatinib Mesylate tablets Farhat Nasim6 March 2019 9:30 AM ISTImatinib Mesylate is a generic version of Novartis Pharmaceuticals Corporation's Gleevec tablets in the same strengths, Lupin said in a filing to BSE....
Lupin launches Minocycline Hydrochloride extended release tablets in US Farhat Nasim27 Feb 2019 9:40 AM ISTThe company has launched Minocycline Hydrochloride extended-release tablets USP in the strength of 55 mg, after receiving approval from the United...
Shilpa Medicare gets USFDA nod for Gemcitabine to treat types of cancer Farhat Nasim27 Feb 2019 9:30 AM ISTThe company has received US Food and Drug Administration (USFDA) approval for its Abbreviated New Drug Application (ANDA), Gemcitabine for injection...
Lupin gets USFDA nod to Methylprednisolone tablets to treat inflammation Farhat Nasim26 Feb 2019 9:50 AM ISTThe company has received approval from the US Food and Drug Administration (USFDA) to market Methylprednisolone tablets, a generic version of...
USFDA completes audit for Dr Reddys Shreveport plant, no observations issued Medical Dialogues Bureau23 Feb 2019 9:30 AM IST"The audit of our formulations Shreveport plant, Louisiana, USA, by the United States Food and Drug Administration (USFDA) has been completed with...
Alembic Pharma gets USFDA nod for Acetazolamide extended release capsules Farhat Nasim21 Feb 2019 9:45 AM ISTAcetazolamide extended-release capsule is therapeutically equivalent to the reference listed drug, Diamox Sequels, 500 mg, of Teva Branded...
Alembic Pharma gets USFDA nod for Olopatadine Hydrochloride ophthalmic solution Farhat Nasim17 Feb 2019 9:30 AM ISTThe company has received approval from the US Food and Drug Administration (USFDA) for its abbreviated new drug application (ANDA) Olopatadine...
Glenmark gets tentative USFDA nod to breast cancer injection Fulvestrant Farhat Nasim8 Feb 2019 11:40 AM ISTFulvestrant injection is a generic version of AstraZeneca Pharmaceuticals LP's Faslodex injection in the same strength, it added. The Faslodex...
